Literature DB >> 26811028

Oxaloacetate enhances neuronal cell bioenergetic fluxes and infrastructure.

Heather M Wilkins1,2, Scott Koppel2,3, Steven M Carl2, Suruchi Ramanujan2, Ian Weidling2,3, Mary L Michaelis2,4, Elias K Michaelis2,4, Russell H Swerdlow1,2,3,5.   

Abstract

We tested how the addition of oxaloacetate (OAA) to SH-SY5Y cells affected bioenergetic fluxes and infrastructure, and compared the effects of OAA to malate, pyruvate, and glucose deprivation. OAA displayed pro-glycolysis and pro-respiration effects. OAA pro-glycolysis effects were not a consequence of decarboxylation to pyruvate because unlike OAA, pyruvate lowered the glycolysis flux. Malate did not alter glycolysis flux and reduced mitochondrial respiration. Glucose deprivation essentially eliminated glycolysis and increased mitochondrial respiration. OAA increased, while malate decreased, the cell NAD+/NADH ratio. Cytosolic malate dehydrogenase 1 protein increased with OAA treatment, but not with malate or glucose deprivation. Glucose deprivation increased protein levels of ATP citrate lyase, an enzyme which produces cytosolic OAA, whereas OAA altered neither ATP citrate lyase mRNA nor protein levels. OAA, but not glucose deprivation, increased cytochrome oxidase subunit 2, PGC1α, PGC1β, and PGC1 related co-activator protein levels. OAA increased total and phosphorylated SIRT1 protein. We conclude that adding OAA to SH-SY5Y cells can support or enhance both glycolysis and respiration fluxes. These effects appear to depend, at least partly, on OAA causing a shift in the cell redox balance to a more oxidized state, that it is not a glycolysis pathway intermediate, and possibly its ability to act in an anaplerotic fashion. We examined how oxaloacetate (OAA) affects bioenergetic fluxes. To advance the understanding of how OAA mediates these changes, we compared the effects of OAA to malate, pyruvate, and glucose deprivation. We further examined how OAA affects levels of enzymes that facilitate its cytosolic metabolism, and found OAA increased the expression of malate dehydrogenase 1 (MDH1-cytosolic). We propose the following: OAA supports both glycolysis and respiration fluxes, shifts the cell redox balance toward a more oxidized state, and acts in an anaplerotic fashion. Abbreviations not defined in the text: MDH2, malate dehydrogenase 2 (mitochondrial).
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  bioenergetics; glycolysis; mitochondria; oxaloacetate; respiration

Mesh:

Substances:

Year:  2016        PMID: 26811028      PMCID: PMC5482267          DOI: 10.1111/jnc.13545

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

Review 1.  The key role of anaplerosis and cataplerosis for citric acid cycle function.

Authors:  Oliver E Owen; Satish C Kalhan; Richard W Hanson
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

Review 2.  Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer's Disease.

Authors:  Heather M Wilkins; Russell H Swerdlow
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 3.  Human neuroblastoma cells in culture: a model for neuronal cell differentiation and function.

Authors:  S Påhlman; S Mamaeva; G Meyerson; M E Mattsson; C Bjelfman; E Ortoft; U Hammerling
Journal:  Acta Physiol Scand Suppl       Date:  1990

Review 4.  Brain aging, Alzheimer's disease, and mitochondria.

Authors:  Russell H Swerdlow
Journal:  Biochim Biophys Acta       Date:  2011-09-02

Review 5.  Transcriptional regulation of neuronal genes and its effect on neural functions: NAD-dependent histone deacetylase SIRT1 (Sir2alpha).

Authors:  Shin Hisahara; Susumu Chiba; Hiroyuki Matsumoto; Yoshiyuki Horio
Journal:  J Pharmacol Sci       Date:  2005-07-09       Impact factor: 3.337

Review 6.  Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network.

Authors:  Richard C Scarpulla
Journal:  Biochim Biophys Acta       Date:  2010-10-13

7.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

8.  Glycolysis-respiration relationships in a neuroblastoma cell line.

Authors:  Russell H Swerdlow; Lezi E; Daniel Aires; Jianghua Lu
Journal:  Biochim Biophys Acta       Date:  2013-01-10

Review 9.  Respiratory metabolism: glycolysis, the TCA cycle and mitochondrial electron transport.

Authors:  Alisdair R Fernie; Fernando Carrari; Lee J Sweetlove
Journal:  Curr Opin Plant Biol       Date:  2004-06       Impact factor: 7.834

10.  Mitochondrial Manipulation and the Quest for Alzheimer's Treatments.

Authors:  Russell H Swerdlow
Journal:  EBioMedicine       Date:  2015-03-27       Impact factor: 8.143

View more
  22 in total

Review 1.  Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities.

Authors:  Judit M Perez Ortiz; Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2019-03-06       Impact factor: 8.739

Review 2.  The vital role of ATP citrate lyase in chronic diseases.

Authors:  Amrita Devi Khwairakpam; Kishore Banik; Sosmitha Girisa; Bano Shabnam; Mehdi Shakibaei; Lu Fan; Frank Arfuso; Javadi Monisha; Hong Wang; Xinliang Mao; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  J Mol Med (Berl)       Date:  2019-12-19       Impact factor: 4.599

Review 3.  Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease.

Authors:  Rikki Hullinger; Luigi Puglielli
Journal:  Behav Brain Res       Date:  2016-05-07       Impact factor: 3.332

4.  Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.

Authors:  Vedad Delic; Jeddidiah W D Griffin; Sandra Zivkovic; Yumeng Zhang; Tam-Anh Phan; Henry Gong; Dale Chaput; Christian Reynes; Vinh B Dinh; Josean Cruz; Eni Cvitkovic; Devon Placides; Ernide Frederic; Hamed Mirzaei; Stanley M Stevens; Umesh Jinwal; Daniel C Lee; Patrick C Bradshaw
Journal:  Neuromolecular Med       Date:  2017-06-15       Impact factor: 3.843

Review 5.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 6.  Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Rebecca Parodi-Rullán; Je Yeong Sone; Silvia Fossati
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Liver-derived cell lines from cavefish Astyanax mexicanus as an in vitro model for studying metabolic adaptation.

Authors:  Jaya Krishnan; Yan Wang; Olga Kenzior; Huzaifa Hassan; Luke Olsen; Dai Tsuchiya; Alexander Kenzior; Robert Peuß; Shaolei Xiong; Yongfu Wang; Chongbei Zhao; Nicolas Rohner
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

8.  The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation.

Authors:  Sharon J Manley; Wen Liu; Danny R Welch
Journal:  J Mol Med (Berl)       Date:  2017-06-08       Impact factor: 4.599

Review 9.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Authors:  Stephen C Cunnane; Mark J Millan; Eugenia Trushina; Cecilie Morland; Alessandro Prigione; Gemma Casadesus; Zane B Andrews; M Flint Beal; Linda H Bergersen; Roberta D Brinton; Suzanne de la Monte; Anne Eckert; Jenni Harvey; Ross Jeggo; Jack H Jhamandas; Oliver Kann; Clothide Mannoury la Cour; William F Martin; Gilles Mithieux; Paula I Moreira; Michael P Murphy; Klaus-Armin Nave; Tal Nuriel; Stéphane H R Oliet; Frédéric Saudou; Mark P Mattson; Russell H Swerdlow
Journal:  Nat Rev Drug Discov       Date:  2020-07-24       Impact factor: 84.694

10.  Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients.

Authors:  Eric D Vidoni; In-Young Choi; Phil Lee; Gregory Reed; Na Zhang; Joseph Pleen; Jonathan D Mahnken; Jonathan Clutton; Annette Becker; Erica Sherry; Rebecca Bothwell; Heidi Anderson; Robert A Harris; William Brooks; Heather M Wilkins; Lisa Mosconi; Jeffrey M Burns; Russell H Swerdlow
Journal:  Alzheimers Dement       Date:  2020-07-27       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.